Watch the Livestream Recording | Presented by Bruker
Watch the full recording of our recent lab tour showing how Sapient’s next-generation, ultra-high throughput rapid liquid chromatography-mass spectrometry (rLC-MS) platform leverages the unique bioanalytical capabilities of the Bruker timsTOF Pro 2 to enable large-scale, nontargeted biomarker profiling. See how the systems are integrated into a full discovery pipeline to rapidly process and derive actionable insight from the generated data.
The livestream features Q&A with Sapient’s Mo Jain, Founder and CEO; Tao Long, Co-Founder and Head of Data Sciences; Saumya Tiwari, Co-Founder and Head of Chemical Discovery; and Jeramie Watrous, Co-Founder and Head of Analytical R&D. Complete the form to watch now!
“Live from the Lab” at Sapient: On-Demand Virtual Lab Tour with Bruker
Watch the Livestream Recording | Presented by Bruker Watch the full recording of our recent lab tour showing how Sapient’s next-generation, ultra-high throughput rapid liquid chromatography-mass spectrometry (rLC-MS) platform leverages the unique bioanalytical capabilities of the Bruker timsTOF Pro 2 to enable large-scale, nontargeted biomarker profiling. Read More
Experts On… Biomarker Translation of Discoveries in Blood to Other Matrices
Having a multidisciplinary team gives us deep & diverse expertise to tap across our discovery endeavors. This series shares those insights with you. While blood is a rich resource for small molecule biomarker discovery, Sapient’s approaches can be leveraged across diverse sample types including tissue, urine,… Read More
Small Molecule Biomarkers + Adaptive Clinical Trials: Optimize Dosing & Timing of Treatments
Adaptive clinical trial designs are an emerging approach that bring flexibility to traditional linear study designs by adding a “review, adapt” loop that allows adjustments to be made during the course of the trial if warranted. Adaptive designs can be particularly helpful to optimize dosing and timing of treatment… Read More
Experts On… Translating Biomarker Discoveries into Real-World Assays
Having a multidisciplinary team gives us deep & diverse expertise to tap across our discovery endeavors. This series shares those insights with you. The translation of small molecule biomarker discoveries into clinical assays for real-world use is critical to ensure important measures of biological processes, disease… Read More
Experts On… Delivering Value to Biopharma Sponsors
Having a multidisciplinary team gives us deep & diverse expertise to tap across our discovery endeavors. This series shares those insights with you. Small molecule biomarkers provide the next layer of biological insight to help complete the picture of human health and disease that genetics and… Read More
Experts On… The Impact of Chemical Discovery at Scale
Having a multidisciplinary team gives us deep & diverse expertise to tap across our discovery endeavors. This series shares those insights with you. Advancing precision medicine requires better understanding not only of how one patient differs from another, but also the factors that cause diseases and… Read More
Experts On… Making Biomarker Discoveries Actionable
Having a multidisciplinary team gives us deep & diverse expertise to tap across our discovery endeavors. This series shares those insights with you. Actionable insight. That is what’s needed to move from nontargeted discovery screenings to development of targeted clinical assays that can provide new diagnostics… Read More
Experts On… Multi-Omics Data Integration
Having a multidisciplinary team gives us deep & diverse expertise to tap across our discovery endeavors. This series shares those insights with you. To achieve the statistical power for robust discovery of biological insight, we often need to integrate multiple omics datasets – including high dimensional… Read More
Experts On… Machine Learning in Biomarker Discovery
Having a multidisciplinary team gives us deep & diverse expertise to tap across our discovery endeavors. This series shares those insights with you. How can machine learning (ML) be used to boost biomarker discovery potential? Sapient’s Co-Founder and Head of Chemical Discovery, Dr. Saumya Tiwari, shares… Read More
Experts On… Approaching Experimental Design
Having a multidisciplinary team gives us deep & diverse expertise to tap across our discovery endeavors. This series shares those insights with you. What does an engagement with Sapient look like? Hear from Dr. Tanya Nguyen, Sapient’s Head of Operations, as she explains how her team… Read More
